Respiratory Disease
178
22
28
88
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Research Maturity
88 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.4%
6 terminated out of 178 trials
93.6%
+7.1% vs benchmark
3%
6 trials in Phase 3/4
8%
7 of 88 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 88 completed trials
Clinical Trials (178)
Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder
A New Portable Device for Non-invasive Ventilatory Support
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
Post COVID-19 REspiratory Mechanisms and the Efficacy of a Breathing Exercise Intervention for DYsregulated Breathing
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19
Children's Health in London and Luton (CHILL)
Comparing 6-Minute Walk Tests for Ambulatory Oxygen Assessment
Optimization of Exhaled Biomarker Collection and Analysis
12 Steps of a Modified Handwashing Program on Health Outcomes and School Absenteeism
Comparison of Multiple Oxygenation Targets With Different Oximeters in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Patients- Impact on Oxygen Flows
Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention
Non-invasive Assessment of Inspiratory Effort and Tidal Distension During Non-invasive Ventilation (INSPIRE)
Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
Clinical Feasibility of the Myotrace Measurement
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Radiofrequency in Patients Post Covid 19 With Respiratory Sequelae.
Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation
Procedural Skills Transfer in Bronchoscopy
REspiratory reHABilitation and PSYchiatric Comorbidities
Kinshasa Lung Ultrasound Approach Validation